Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Notice of AGM and Posting of Annual Report

21st May 2025 17:00

RNS Number : 3740J
Diaceutics PLC
21 May 2025
 

Diaceutics PLC

 

Notice of AGM and Posting of Annual Report

 

New York, Belfast and London, 21 May 2025 - Diaceutics PLC (AIM: DXRX), a leading technology and solutions provider to the pharma and biotech industry, announces that it will today post its Annual Report for the year ended 31 December 2024 to shareholders together with the Notice of the 2025 Annual General Meeting ("AGM").

 

The Company will hold its AGM on Wednesday, 18 June 2025 at 10.30am at First Floor, Building Two, Dataworks at Kings Hall Health and Wellbeing Park, Belfast, County Antrim BT9 6GW.

 

The Annual Report and Notice of AGM will also be available shortly on the Company's website at www.diaceutics.com

 

Enquiries: 

Diaceutics PLC 

Ryan Keeling, Chief Executive Officer  

Nick Roberts, Chief Financial Officer 

Tel: +44 (0)28 9040 6500

[email protected]

 

Canaccord Genuity Limited (Nomad & Broker) 

Tel: +44 (0)20 7523 8000

Simon Bridges, Andrew Potts, Harry Rees

 

About Diaceutics

At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world's leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX - The Diagnostics Network®.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOAGUGDUIBDDGUG

Related Shares:

Diaceutics
FTSE 100 Latest
Value8,717.97
Change-21.29